Bluejay Diagnostics
BJDX
4 hedge funds and large institutions have $47.8K invested in Bluejay Diagnostics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 2 → 4 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
14% less capital invested
Capital invested by funds: $55.7K → $47.8K (-$7.93K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$9.04K |
| 2 |
Renaissance Technologies
New York
|
+$9.04K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$9.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$5.01K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4.28K |
| 3 |
VF
Virtu Financial
New York
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $13K | +$9.04K | +1 | +100% |
|
|
HF
2
HRT Financial
New York
| $8K | +$9.04K | +1 | New |
|
3
Geode Capital Management
Boston,
Massachusetts
| $7.86K | – | – | – |
|
|
TSS
4
Two Sigma Securities
New York
| $7.12K | +$9.04K | +1 | New |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $4.18K | – | – | – |
|
6
Northern Trust
Chicago,
Illinois
| $3.08K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $2.67K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $1.36K | – | – | – |
|
|
CAS
9
Coppell Advisory Solutions
Coppell,
Texas
| $407 | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $131 | – | – | – |
|
11
Wells Fargo
San Francisco,
California
| $19 | – | – | – |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$4.28K | – | – |
|
|
13
Jane Street
New York
| – | -$5.01K | – | – |
|
|
VF
14
Virtu Financial
New York
| – | -$4K | – | – |
|
BJDX Hedge Fund Activity: Q2 2023 in Review
4 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q2 2023, worth a combined $47.8K — down 14% from $55.7K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BJDX positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $9.04K. The largest seller was Jane Street, cutting an estimated $5.01K.
- 4 institutional investors held Bluejay Diagnostics (BJDX) as of Q2 2023, up from 2 in Q1 2023.
- Funds reported $47.8K of Bluejay Diagnostics stock for Q2 2023, down 14% quarter-over-quarter.
- 2 funds opened new Bluejay Diagnostics positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest Bluejay Diagnostics buyer in Q2 2023 was HRT Financial, an estimated $9.04K added.
- The largest Bluejay Diagnostics seller in Q2 2023 was Jane Street, an estimated $5.01K sold.
Based on aggregated 13F filings for Q2 2023.